Dopamine receptors in the central nervous system.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001549:Benzamides / Q000378:metabolism; D001665:Binding Sites; D001923:Brain Chemistry; D002090:Butyrophenones / Q000378:metabolism; D002490:Central Nervous System / Q000032:analysis / Q000187:drug effects / Q000502:physiology*; D003342:Corpus Striatum / Q000502:physiology; D003714:Denervation; D006358:Hot Temperature; D006801:Humans; D009407:Nerve Block; D010643:Phenoxybenzamine / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology; D011869:Radioligand Assay; D011954:Receptors, Dopamine / Q000302:isolation & purification / Q000502:physiology*; D012160:Retina / Q000032:analysis; D013268:Stimulation, Chemical; D013378:Substantia Nigra / Q000032:analysis; D013764:Tetrahydronaphthalenes / Q000494:pharmacology; D013892:Thioxanthenes / Q000378:metabolism; D013997:Time Factors; D014018:Tissue Distribution; D014316:Tritium
D001549:Benzamides; D002090:Butyrophenones; D011954:Receptors, Dopamine; D013764:Tetrahydronaphthalenes; D013892:Thioxanthenes; D010643:Phenoxybenzamine; D014316:Tritium; C011639:ADTN; D001058:Apomorphine